Equities

Eden Research PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Eden Research PLC

Actions
Basic MaterialsChemicals
  • Price (GBX)3.90
  • Today's Change0.00 / 0.00%
  • Shares traded63.66k
  • 1 Year change-4.88%
  • Beta1.4208
Data delayed at least 20 minutes, as of Feb 10 2026 16:24 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Eden Research plc is a United Kingdom-based company, which is focused on biopesticides for sustainable agriculture. The Company develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The Company's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products

  • Revenue in GBP (TTM)3.62m
  • Net income in GBP-2.35m
  • Incorporated1995
  • Employees23.00
  • Location
    Eden Research PLC67C Innovation Drive, Milton ParkOXFORD OX14 4RQUnited KingdomGBR
  • Phone+44 128 535 9555
  • Fax+44 199 377 6480
  • Websitehttps://www.edenresearch.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Quantum Helium Ltd260.83k-3.77m12.39m----3.82--47.49-0.0002-0.00030.000010.00010.0686--3.43---99.20-37.91-126.90-44.6055.9040.85-1,446.77-375.92----0.00--170.40-19.54-371.30--42.83--
Unigel Group PLC33.26m2.27m12.65m57.005.832.105.090.38030.15020.15022.140.41742.054.19--583,595.9014.00--41.73--19.80--6.82--0.7564--0.0017--2.49--173.19------
Kropz PLC28.13m3.70m13.25m26.002.430.25052.210.47080.00350.00350.02070.03370.24366.3012.841,082,092.004.68--13.32---27.24--19.19--0.0681--0.5079--------------
Itaconix PLC6.24m-910.15k16.09m22.00--2.32--2.58-0.0686-0.06860.46860.51350.62422.177.51283,717.30-9.10-23.66-10.80-33.3833.4631.09-14.58-30.802.48--0.1646---17.3338.24-21.42--71.99--
Hardide Plc6.03m178.00k18.13m38.00102.224.6719.303.010.00230.00230.07660.04920.784915.145.06--2.32-15.482.95-18.2957.3146.382.95-29.151.551.930.3823--27.484.86113.48---55.96--
Symphony Environmental Technologies plc6.08m-1.31m18.32m28.00--15.33--3.01-0.0058-0.00580.02690.00511.285.762.75217,107.10-27.40-28.01-74.83-70.8549.1540.42-21.47-21.420.9054-3.890.6996--3.78-4.3338.35---33.17--
Eden Research plc3.62m-2.35m20.80m23.00--1.97--5.75-0.0044-0.00440.00680.01980.25372.742.44157,183.00-16.45-21.32-19.76-25.0051.8147.50-64.84-131.631.90-81.550.0511--34.7918.7170.64--23.15--
Emmerson PLC0.00-18.60m28.30m-----------0.0158-0.01580.00-0.00020.00-------203.14-39.00-210.95-40.91-----------211.61---------761.30------
Atome PLC0.00-5.13m30.65m10.00--25.74-----0.1091-0.10910.000.02340.00----0.00-81.05---193.09--------------0.3192-------6.51------
Haydale PLC3.61m-6.60m32.27m63.00--3.03--8.95-0.0032-0.00320.00140.00140.27420.76693.8257,253.97-50.16-36.12-62.95-44.4759.0561.48-182.92-137.131.18-17.280.2723--12.076.810.8921---18.82--
Carclo plc117.50m1.84m37.59m958.0020.67--4.750.31990.02480.02481.58-0.12881.18--5.83122,646.101.850.83492.801.20--54.561.570.7650.95426.041.420.00-8.631.87125.73---33.58--
Zinnwald Lithium PLC0.00-2.72m38.59m14.00--1.10-----0.0057-0.00570.000.06490.00----0.00-7.50-9.51-7.59-9.79------------0.0055-------3.52--69.37--
Data as of Feb 10 2026. Currency figures normalised to Eden Research PLC's reporting currency: UK Pound GBX

Institutional shareholders

36.72%Per cent of shares held by top holders
HolderShares% Held
Hargreaves Lansdown Asset Management Ltd.as of 31 Dec 202456.61m10.61%
Octopus Investments Ltd.as of 31 Dec 202441.55m7.79%
Canaccord Genuity Wealth Ltd.as of 31 Dec 202430.20m5.66%
Unicorn Asset Management Ltd.as of 31 Jan 202623.08m4.33%
J. M. Finn & Co. Ltd.as of 31 Dec 202422.38m4.20%
Rathbones Asset Management Ltd.as of 31 Dec 202421.57m4.04%
Oberon Investments Ltd. (GB Investment Management)as of 30 Jun 2025426.44k0.08%
More ▼
Data from 31 Oct 2025 - 04 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.